Navigation Links
Hooper Holmes Concludes Sale of Medicals Direct
Date:10/11/2007

BASKING RIDGE, N.J., Oct. 11 /PRNewswire-FirstCall/ -- Hooper Holmes (Amex: HH) today announced the sale of Medicals Direct Group, the Company's subsidiary in the United Kingdom, to Brandgold Ltd., a management buyout group organized by Michael Benton, CEO of Medicals Direct. The purchase price was $15.25 million.

Following the terms of the transaction, $14 million (less closing adjustments of approximately $1.2 million), was paid to Hooper Holmes when the sale closed on October 9. Terms specify additional payments to Hooper Holmes of $500,000 within nine months of the closing and $750,000 within 24 months. All payments are in U.S. dollars.

"Divesting Medicals Direct is an important strategic step that will strengthen our balance sheet and enable us to invest in our most strategic businesses," said James Calver, President and CEO of Hooper Holmes.

Hooper Holmes announced the planned sale of Medicals Direct on August 9, 2007. The decision to sell was based on several factors, including the subsidiary's limited ability to significantly contribute to the long-term strategic goals of the Company. The company expects to record a net gain of approximately $10 million in connection with the transaction.

About Hooper Holmes

Hooper Holmes is the leader in collecting personal health data and transforming it into useful information, enabling customers to take actions that manage or reduce their risks and expenses. As the leading provider of risk assessment services for the insurance industry, Hooper Holmes provides insurers with the widest range of medical exam, data collection, laboratory testing and underwriting services in the industry.

With presence in over 250 markets and a network of more
'/>"/>

SOURCE Hooper Holmes
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Katee Holmes Vs Katie Holmes Case of Losing Virginity
2. Holmes Silences Pregnancy Rumours
3. Baby Bump Sparks Off Pregnancy Rumours Again for Holmes
4. Katie Holmes in most Influential Celebs List
5. Hospitals Appeal to Citizen Groups to Rush Doctors, Paramedicals
6. Nasal Spray Could Take Drugs Direct to Brain.
7. Nasal Spray Could Take Drugs Directly to Brain
8. Energy intake directly related to portion size
9. Drug to stop HIV spread to babies may Indirectly harm The Mother
10. DNA Directory Under Construction For Indian Criminals !
11. Research on HIV takes new direction

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...PRNewswire/ -- A randomized, controlled study comp... invasive treatment called percutaneous disc decom...while both treatments help patients in the short r...e up to two years later. Results of the study, the...nual meeting of the Radiological Society of North ...
(Date:12/2/2009)...c. 2 LeapFrog Investments has anno...ent in AllLife, the innovative South African insur...e investment brings together LeapFrog, the leading...of Africa,s most innovative insurance businesses. ...,, "AllLife has developed a distinctive and pro...
(Date:12/2/2009)...trasound of suspicious areas of the breast, includ...alternative to invasive biopsies for women under a...esented today at the annual meeting of the Radiolo...forming high-quality breast ultrasound, we can red... diagnostic procedures in young women," said senio...
(Date:12/2/2009)...-scale clinical trial presented today at the annua...rica (RSNA) provide the first strong evidence of t...n with dense breasts who are at elevated risk for ...at MRI is highly sensitive in depicting early brea...h ultrasound in addition to mammography significan...
(Date:12/1/2009)...ocate Christ Medical Center in Oak Lawn, Ill. has ...center and the first for Chicago’s south and...he hospital’s plans today (December 1) by th...oard. , Springfield, Ill....k Lawn, Ill. has become the state’s newest k...
Breaking Medicine News(10 mins):Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2Health News:Annual screening with breast ultrasound or MRI could benefit some women 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 2Health News:State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 3
...rofit Growth, RIO DE JANEIRO, Brazil, May 13 Ami...s: AMIL3.SA), the largest,managed care organizatio...lts for the first quarter 2008., ....5% higher than the previous quarter., --...
...mong 52 Companies Recognized for Promoting ..., Minn., May 13 The National Business Group,on He...employers, today,honored Data Recognition Corporat...go: http://www.newscom.com/cgi-bin/prnh/20080513/...
...the benefits of Hemodiafiltration therapy and ...atients, NEW YORK, May 13 Nephros, Inc. (Amex: ...keting products designed to,improve the quality of...that it exhibited at the XLV ERA-EDTA Congress in,...
...M) ICD represent entirely new platforms, NATICK, ...: BSX ) today announced U.S. Food and Drug Admini...resynchronization therapy,defibrillator (CRT-D) an...eath and are the result of a,multi-year research a...
...RI, CT for false positives, study found , ... imaging technique to detect head and neck cancer ...ly or more accurate diagnosis of the disease, new ...ther head and neck squamous cell cancer has spread...
...nior Technology Advisor, SALT LAKE CITY, May 13 ...(Nasdaq: SNCI ), a leading producer of advanced,d...aguskus has stepped down,as Chairman of the Board....t, the Board of Directors appointed CEO Sam,Westov...
Other Medicine News:Health News:Amil Has Strong Growth With High Profitability 2Health News:National Business Group on Health Honors Data Recognition Corporation as One of Best Employers for Healthy Lifestyles 2Health News:National Business Group on Health Honors Data Recognition Corporation as One of Best Employers for Healthy Lifestyles 3Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 2Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 3Health News:Nephros Exhibits at the XLV ERA-EDTA Congress in Stockholm, Sweden, May 10-13, 2008 4Health News:Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 2Health News:Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 3Health News:Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death 4Health News:High-Tech Imaging No Better for Diagnosing Head/Neck Cancers 2Health News:Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations 2Health News:Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations 3
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 N... late-breaking presentation on Tasigna® (nilo...d leukemia, demonstrate the strength of the compan...patients. ,, The new data, at the 51st America...xposition, highlight the company,s current therapi...
(Date:12/1/2009)...MECULA, Calif., Dec. 1 P...rd: PSTX) announced today that it has appointed Ma...ncial Officer, Treasurer and Corporate Secretary, ...ce 2008. Prior to joining Patient Safety Technolo...hief Financial Officer, Treasurer and Corporate Se...
(Date:12/1/2009)...ONDO BEACH, Calif., Dec. 1 Reprodu... Elective Single Embryo Transfer (eSET) Encouragem...atients with good embryo quality and a good progno... twins by transferring a single embryo. ,, The ...today is reducing the number of multiple pregnanci...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 1CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 2CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 3eDiets com 28R 29 Granted Continued Listing by NASDAQ Panel 54840 1eDiets com 28R 29 Granted Continued Listing by NASDAQ Panel 54840 2Are You Connected 3F AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 54836 1Are You Connected 3F AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 54836 2Are You Connected 3F AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 54836 3
...lif.--(BUSINESS WIRE)--Apr 18, 2007 - Avanir,Pharm...top-line,results from the company,s Phase III clin...via(TM) (dextromethorphan,hydrobromide/quinidine s...onist, in diabetic neuropathic pain., The primary ...,entries for the Pain Rating Scale as defined in t...
...with a Bavituximab Equivalent and Irradiated Tumor... in Controls in a,Preclinical Model of Brain Cance...7,/PRNewswire-FirstCall/ -- Peregrine Pharmaceutic...pany developing targeted,monoclonal antibodies for...V) infection, today announced preclinical studies,...
Other Medicine Technology:Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 2Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 3Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 4Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 6Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 2Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 3Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 4Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 5Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 6
...c has been a key participant in the area of blood ...us Medtronic autotransfusion systems allowed clini...latelets, as well as to determine requirements for...ch plasma (PRP) for a small amount of autologous b...
RX HERCULINK® PLUS Biliary Stent System
Response Catheter
Fast-Cath™ Guiding Introducers
Medicine Products: